MedPath

Effect of adding midazolam to bupivacaine during spinal anaesthesia

Completed
Conditions
ASA I and II patients posted for elective infra umbilical surgery
Registration Number
CTRI/2013/04/003600
Lead Sponsor
Institute of Post Graduate Medical Education and Reseach Kolkata
Brief Summary

Background:Spinal anesthetic technique is one of the common procedures used for variousinfra umbilical surgeries. Duration of post operative analgesia is one of theimportant concerns while  performing thisprocedure. Several adjuvants have been tried along with local anesthetic forprolonging the duration of analgesia. In this study we have observed the effectof midazolam as an adjuvant in patients undergoing infra umbilical surgery.

Settingsand Design: A prospective, randomized, double blinded, parallel group, placebocontrolled, open label study tertiary care hospital.

Methods:90 adult patients aged 18 – 60 years, of American Society of Anaesthesiologists(ASA) status I and II, scheduled for elective infraumbilical surgery, were randomlyallocated in two groups. Each patient in group “B†received bupivacaine 12.5mg along with 0.4 ml of normal salinein the subarachnoid block, and patients of group “BM†received 12.5 mgbupivacaine along with preservative free midazolam 0.4ml (2mg). Duration ofanalgesia was calculated from time of administration of the block torequirement of rescue analgesic as demanded by the patient in the postoperative period.

Statisticalanalysis: SPSS v17.0 was used for analysis of data. A p-value < 0.05 wasconsidered statistically significant.

Results& conclusion: Use of midazolam as adjuvant with the local anestheticsignificantly increases the duration of analgesia and motor block but a lessPONV.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
90
Inclusion Criteria

adult patients of ASA physical status I and II and aged 18 – 60 years undergoing elective infra-umbilical (gynaecologic/urologic) under spinal subarachnoid block anesthesia were included into the study.

Exclusion Criteria

Patients refusing to participate, Patients with known allergic to local anaesthetic and midazolam, Patients suffering from chronic pain, and pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of analgesiatime from administration of block to demand of first rescue analgesia in post operative period
Secondary Outcome Measures
NameTimeMethod
Duration of motor blockHemodynamic changes

Trial Locations

Locations (1)

IPGME&R and SSKM Hospital, Kolkata

🇮🇳

Kolkata, WEST BENGAL, India

IPGME&R and SSKM Hospital, Kolkata
🇮🇳Kolkata, WEST BENGAL, India
Dr Anirban Chattopadhyay
Principal investigator
09867198844
smaitra.ipgmer@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.